Ono Pharmaceutical Co Ltd (OPHLY)
4.542
-0.01
(-0.18%)
USD |
OTCM |
Jul 01, 15:59
Ono Pharmaceutical Profit Margin (Quarterly): 15.46% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.46% |
December 31, 2023 | 27.48% |
September 30, 2023 | 30.77% |
June 30, 2023 | 26.51% |
March 31, 2023 | 15.78% |
December 31, 2022 | 27.24% |
September 30, 2022 | 29.88% |
June 30, 2022 | 27.62% |
March 31, 2022 | 17.68% |
December 31, 2021 | 18.83% |
September 30, 2021 | 25.62% |
June 30, 2021 | 27.56% |
March 31, 2021 | 12.02% |
December 31, 2020 | 31.54% |
September 30, 2020 | 24.29% |
June 30, 2020 | 28.69% |
March 31, 2020 | 11.74% |
December 31, 2019 | 24.92% |
September 30, 2019 | 21.97% |
June 30, 2019 | 22.07% |
March 31, 2019 | 12.85% |
December 31, 2018 | 18.13% |
September 30, 2018 | 18.60% |
June 30, 2018 | 21.39% |
March 31, 2018 | 14.44% |
Date | Value |
---|---|
December 31, 2017 | 25.57% |
September 30, 2017 | 15.59% |
June 30, 2017 | 19.33% |
March 31, 2017 | 23.81% |
December 31, 2016 | 27.21% |
September 30, 2016 | 16.01% |
June 30, 2016 | 23.28% |
March 31, 2016 | 12.11% |
December 31, 2015 | 17.35% |
September 30, 2015 | 6.99% |
June 30, 2015 | 26.48% |
March 31, 2015 | -9.58% |
December 31, 2014 | 27.68% |
September 30, 2014 | 1.22% |
June 30, 2014 | 9.14% |
March 31, 2014 | 1.45% |
December 31, 2013 | 20.53% |
September 30, 2013 | 10.58% |
June 30, 2013 | 21.42% |
March 31, 2013 | 6.50% |
December 31, 2012 | 23.92% |
September 30, 2012 | 7.92% |
June 30, 2012 | 22.37% |
March 31, 2012 | 20.26% |
December 31, 2011 | 21.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
11.74%
Minimum
Mar 2020
31.54%
Maximum
Dec 2020
23.45%
Average
25.62%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | -0.29% |
Nxera Pharma Co Ltd | -71.16% |
PeptiDream Inc | -19.94% |
Healios KK | -24.24K% |
AnGes Inc | -1.61K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 16.43% |
Return on Assets | 14.34% |
Return on Invested Capital | 16.43% |
Gross Profit Margin (Quarterly) | 71.92% |
Operating Margin (Quarterly) | 13.58% |
Return on Net Operating Assets | 36.51% |